HealthEquity (NASDAQ:HQY) EVP Sells 2,354 Shares

HealthEquity, Inc. (NASDAQ:HQY) EVP Michael Henry Fiore sold 2,354 shares of the stock in a transaction on Friday, July 10th. The stock was sold at an average price of $95.00, for a total transaction of $223,630.00. Following the sale, the executive vice president directly owned 52,244 shares in the company, valued at $4,963,180. This trade represents a 4.31% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Michael Henry Fiore also recently made the following trade(s):

• On Thursday, July 2nd, Michael Henry Fiore sold 2,470 shares of HealthEquity stock. The shares were sold at an average price of $95.00, for a total transaction of $234,650.00.
• On Friday, May 29th, Michael Henry Fiore sold 3,142 shares of HealthEquity stock. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00.

HealthEquity Stock Performance

HQY traded down $1.16 on Tuesday, hitting $94.50. 1,049,399 shares of the company’s stock were exchanged, compared to its average volume of 1,007,290. The firm has a market cap of $7.90 billion, a PE ratio of 35.39, a P/E/G ratio of 1.59 and a beta of 0.21. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $105.96. The stock has a fifty day moving average of $87.73 and a two-hundred day moving average of $84.62. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, research analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on HQY. Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, March 19th. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Citizens Jmp boosted their price target on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. Finally, Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a research report on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.57.

Hedge Funds Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently made changes to their positions in HQY. Acumen Wealth Advisors LLC acquired a new stake in HealthEquity in the 4th quarter valued at approximately $27,000. Aster Capital Management DIFC Ltd acquired a new position in HealthEquity during the 4th quarter worth $28,000. Caitong International Asset Management Co. Ltd boosted its position in HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after acquiring an additional 293 shares during the period. Leonteq Securities AG grew its stake in shares of HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after purchasing an additional 235 shares in the last quarter. Finally, Axiom Investment Management LLC bought a new position in shares of HealthEquity in the first quarter worth $33,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.